Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

about

Characterisation of a Putative Glutamate 5- Kinase from Leishmania donovani.Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

P2860

Q54108724-DA840FD6-DEDB-4CEF-A3FF-43296361B32A Q57190987-043DB7CD-ABD3-4189-8C93-4811C94E64A4

P2860

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

Item

http://www.wikidata.org/entity/Q47702679

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@en

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@nl

type

Item

label

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@en

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@nl

prefLabel

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@en

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@nl

P1476

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

@en

P2093

Ana Paula C A Lima

http://www.w3.org/2001/XMLSchema#string

Carolina M C Catta-Preta

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Comparative genomic analysis of three Leishmania species that cause diverse human disease

The genome of the kinetoplastid parasite, Leishmania major

LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana.

Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis

Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development

A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes

Retention and loss of RNA interference pathways in trypanosomatid protozoans

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase

Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs

P304

467-477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1021/ACSINFECDIS.7B00244

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy C. Mottram

Nathaniel G Jones

A P Lima

Carolina M C Catta-Preta

P577

2018-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29384366

http://www.w3.org/2001/XMLSchema#string

P921

Chin-hu̍t seng-bu̍t

biomedical investigative technique

protozoan proteins

P932

5902788

http://www.w3.org/2001/XMLSchema#string

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

about

P2860

P2860

Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932